Androgenic alopecia
Clinical trials for Androgenic alopecia explained in plain language.
Never miss a new study
Get alerted when new Androgenic alopecia trials appear
Sign up with your email to follow new studies for Androgenic alopecia, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could stem cell 'messages' regrow hair? new trial begins.
Disease control CompletedThis study tests whether tiny particles from stem cells (exosomes) can safely help regrow hair in men with androgenic alopecia (male pattern baldness). The exosomes are delivered into the scalp using a microneedle device. The trial will enroll 18 men aged 18 to 60 with mild to mo…
Matched conditions: ANDROGENIC ALOPECIA
Sponsor: Fujian Medical University Union Hospital • Aim: Disease control
Last updated Sep 04, 2026 00:00 UTC
-
Can a daily capsule thicken thinning hair? a trial puts three doses to the test
Disease control CompletedThis clinical trial is testing whether a daily oral supplement called SesZen-Bio can improve hair thickness, density, and growth in people with mild to moderate androgenic alopecia (common pattern hair loss). About 72 adults aged 25 to 45 will be randomly assigned to one of three…
Matched conditions: ANDROGENIC ALOPECIA
Sponsor: NovoBliss Research Pvt Ltd • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
PRP shots show promise for thinning hair, but not a cure
Disease control CompletedThis study tested whether injecting a person's own concentrated platelets (PRP) into the scalp can improve hair growth in men with male pattern baldness. Two hundred one men received 3 to 5 sessions of PRP injections. The main goal was to see if hair loss grade improved based on …
Matched conditions: ANDROGENIC ALOPECIA
Phase 2 • Sponsor: zhang li • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New hair serum shows promise in battle against balding
Disease control CompletedThis completed study tested a new hair growth serum called SesZen-Bio against a standard treatment (minoxidil 1%) and a placebo in 108 adults with mild to moderate androgenic alopecia (male or female pattern baldness). Participants applied the serum daily to their scalp for sever…
Matched conditions: ANDROGENIC ALOPECIA
Sponsor: NovoBliss Research Pvt Ltd • Aim: Disease control
Last updated Jun 26, 2026 15:14 UTC